Dario Siniscalco

July 2, 2025

The endocannabinoidome–gut microbiome–brain axis as a novel therapeutic target for autism spectrum disorder

Abstract Introduction: Autism spectrum disorder (ASD) is characterized by disruption of the gut–brain axis, which leads to behavioral, psychiatric, metabolic…

March 25, 2021

Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?

Abstract Persistent deficits in social communication and interaction, and restricted, repetitive patterns of behavior, interests or activities, are the core…

April 17, 2014

The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages

Abstract Background: Immune system dysregulation is well-recognized in autism and thought to be part of the etiology of this disorder.…